Medication info
Double A Tablet 5/10mg

Double A Tablet 5/10mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.94mg / 1 tabletAtorvastatin Calcium›10.36mg / 1 tablet
Manufacturer / importer
IQURE Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201602283 · Approved 2016.04.25

Summary

Main use
Treatment of hypertension and angina, improvement of dyslipidemia, and prevention of cardiovascular disease
Who takes it
Adults
Adult dose
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, amlodipine/atorvastatin. Amlodipine (S-amlodipine) Adults: Administer 5(2.5) mg of amlodipine (S-amlodipine) orally once daily; the dose may be increased to a maximum of 10(5) mg once daily according to the patient's response. Adjust the dose as appropriate according to symptoms. Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during atorvastatin treatment. This medicine may be taken at any time of day, with or without food. 1. Patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and combined (mixed) dyslipidemia (Fredrickson Type Ⅱa and Ⅱb) The recommended initial dose of this medicine is 10 mg once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at doses ranging from 10 mg ∼ 80 mg once daily and may be taken at any time of day, with or without food. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ∼ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. 2. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 mg ∼ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. 3. Patients with renal impairment Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. 4. Older adults The efficacy and safety in older adults aged 70 years or older are similar to those in the general adult patient population.

Ingredients

Manufacturer
IQURE Co., Ltd.

Efficacy & effects

Treatment of hypertension and angina, improvement of dyslipidemia, and prevention of cardiovascular disease

  • Hypertension
  • fixed closure of coronary arteries
  • vasospasm
  • vasoconstriction
  • myocardial ischemia
  • angina
  • coronary heart disease
  • heart failure
  • reduced cardiac output
  • myocardial infarction
  • stroke
  • revascularization
View approved original text

This medication is used for patients who require concurrent use of amlodipine and atorvastatin. Amlodipine treats ischemic heart disease due to coronary artery disease, including hypertension and stable angina, and helps reduce the risk of hospitalization due to angina and the risk of coronary revascularization in patients without heart failure and with normal cardiac output. Atorvastatin is used in patients at high risk for cardiovascular disease to reduce the risk of myocardial infarction, stroke, revascularization, and angina, and to improve cholesterol and triglyceride levels in patients with primary hypercholesterolemia or dyslipidemia. It is also effective in treating hyperlipidemia not controlled by diet and heterozygous familial hypercholesterolemia. The two components work together to provide significant benefits in the treatment of cardiovascular disease and dyslipidemia.

How to take

Adult dose

This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, amlodipine/atorvastatin. Amlodipine (S-amlodipine) Adults: Administer 5(2.5) mg of amlodipine (S-amlodipine) orally once daily; the dose may be increased to a maximum of 10(5) mg once daily according to the patient's response. Adjust the dose as appropriate according to symptoms. Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during atorvastatin treatment. This medicine may be taken at any time of day, with or without food. 1. Patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and combined (mixed) dyslipidemia (Fredrickson Type Ⅱa and Ⅱb) The recommended initial dose of this medicine is 10 mg once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at doses ranging from 10 mg ∼ 80 mg once daily and may be taken at any time of day, with or without food. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ∼ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. 2. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 mg ∼ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. 3. Patients with renal impairment Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. 4. Older adults The efficacy and safety in older adults aged 70 years or older are similar to those in the general adult patient population.

Precautions

This medication should not be used in certain patients. Patients with allergies to this drug or similar medications, severe liver dysfunction, pregnant or breastfeeding women, patients with muscle diseases, etc., should not receive this medication. Additionally, careful monitoring is necessary for patients with severe renal impairment, the elderly, alcoholics, and those with a history of liver disease when using this medication. Liver function and muscle condition should be regularly checked during treatment, and any symptoms such as muscle pain or weakness should be reported immediately. This drug is used to lower blood pressure and regulate cholesterol levels, and is generally well tolerated by most patients, though rare side effects such as rash, headache, dizziness, and gastrointestinal disturbances may occur. If any symptoms suggestive of liver dysfunction or muscle-related issues arise, it is crucial to consult a doctor immediately. This medication may interact with other drugs, therefore it is important to inform your doctor or pharmacist of any other medications you take. Women of childbearing potential must ensure appropriate contraception while taking this drug, and should discontinue use immediately upon confirmation of pregnancy. It's recommended that breastfeeding women do not take this medication. The safety for children and the elderly has not been adequately established, thus special caution is required. In case of overdose, blood pressure may drop excessively or cardiac arrhythmias may occur, necessitating immediate medical attention. This medication should be stored out of reach of children and should not be transferred to another container.

Side effects

Flushing, fatigue, edema, palpitations, dizziness, headache, drowsiness, abdominal pain, nausea, weakness, lethargy, pain, weight gain, weight loss, hypotension, vasculitis, muscle tension, sensory loss, paresthesia, peripheral neuropathy, syncope, dysgeusia, tremor, extrapyramidal disorder, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, dyspepsia, gastritis, gingival hypertrophy, gingival hyperplasia, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, cough, shortness of breath, rhinitis, hair loss, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual impairment, increased urinary frequency, urinary dysfunction, nocturia, hepatitis, jaundice, elevated liver enzyme levels, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, chest pain, hypotension, sinoatrial block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, skin flush, papular rash, heaviness, warmth, impaired glucose tolerance, weakness, lethargy, rhinitis, hyperglycemia, dyspepsia, abdominal bloating, constipation, diarrhea, abdominal pain, pharyngodynia, epistaxis, headache, insomnia, myalgia, arthralgia, limb pain, musculoskeletal pain, muscle spasm, joint swelling, abnormal liver function tests, increased serum CK, nightmares, blurred vision, tinnitus, vomiting, abdominal discomfort, cholestasis, cholestatic jaundice, abnormal liver function test values, gastroenteritis, enteritis, dry mouth, rectal bleeding, esophagitis, belching, glossitis, oral ulcer, stomatitis, gallbladder pain, cheilitis, gastric and duodenal ulcers, dysphagia, melena, gingival bleeding, hyperuricemia, bronchitis, rhinitis, pneumonia, asthma, nasal bleeding, paresthesia, peripheral neuropathy, dizziness, photophobia, drowsiness, memory loss, abnormal dreams, decreased libido, emotional instability, coordination ataxia, torticollis, facial paralysis, hyperactivity, depression, hypertonia, muscle cramps, muscle fatigue, myositis, muscle disorders, arthritis, bursitis, tenosynovitis, myasthenia gravis, neck pain, tendon rupture, immune-mediated necrotizing myopathy, improvement of symptoms with immunosuppressive agents, excessive peripheral vasodilation, reflex tachycardia, systemic hypotension, shock state, non-cardiogenic pulmonary edema, single episode of tonic-clonic seizure, perivascular hemorrhage, edema, mononuclear cell infiltration in perivascular space

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture infiltration. Maintaining a storage temperature between 1 to 30 degrees Celsius at room temperature is advisable.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.